Drugs / HAI-05
HAI-05
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01250795 | Nov 2010 → Jul 2011 | — | Fraunhofer, Center for Molecular Biotechnology | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HAI-05 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01250795 ↗ |
| Known as | FhCMB HAI-05 | “FhCMB HAI-05, a Recombinant Hemagglutinin (rHA) Vaccine Derived From Influenza A/Indonesia/05/2005 (H5N1)” NCT01250795 ↗ |
| Known as | HAI-05 Influenza Vaccine | “HAI-05 Influenza Vaccine” NCT01250795 ↗ |